Immune reconstitution in HIV infection

被引:35
作者
Emery, S [1 ]
Lane, HC [1 ]
机构
[1] NIAID,NIH,BETHESDA,MD 20892
关键词
D O I
10.1016/S0952-7915(97)80112-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Progressive immune deficiency arising during HIV disease reflects the continual degradation and the ultimate deletion of immune specificites defined by the CD4(+) T lymphocyte repertoire. Recent evidence suggests that improvements in the immune function of patients with HIV who receive therapy primarily reflects the expansion of CD4(+) T lymphocyte populations present before therapy commenced. These observations have implications for clinical management, therapeutic strategies, and future research.
引用
收藏
页码:568 / 572
页数:5
相关论文
共 30 条
  • [1] ADLEMAN LM, 1993, J ACQ IMMUN DEF SYND, V6, P144
  • [2] BIGLINO A, 1991, J ACQ IMMUN DEF SYND, V4, P261
  • [3] CD8(+) lymphocyte responses to antiretroviral therapy of HIV infection
    Carr, A
    Emery, S
    Kelleher, A
    Law, M
    Cooper, DA
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (04): : 320 - 326
  • [4] HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION
    CLARK, SJ
    SAAG, MS
    DECKER, WD
    CAMPBELLHILL, S
    ROBERSON, JL
    VELDKAMP, PJ
    KAPPES, JC
    HAHN, BH
    SHAW, GM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 954 - 960
  • [5] DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING
    CLERICI, M
    STOCKS, NI
    ZAJAC, RA
    BOSWELL, RN
    LUCEY, DR
    VIA, CS
    SHEARER, GM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) : 1892 - 1899
  • [6] HIV infection induces changes in CD4(+) T-cell phenotype and depletions within the CD4(+) T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
    Connors, M
    Kovacs, JA
    Krevat, S
    GeaBanacloche, JC
    Sneller, MC
    Flanigan, M
    Metcalf, JA
    Walker, RE
    Falloon, J
    Baseler, M
    Stevens, R
    Feuerstein, I
    Masur, H
    Lane, HC
    [J]. NATURE MEDICINE, 1997, 3 (05) : 533 - 540
  • [7] TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    DAAR, ES
    MOUDGIL, T
    MEYER, RD
    HO, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 961 - 964
  • [8] DAGAGLIO G, 1992, CLIN EXP IMMUNOL, V87, P7
  • [9] IN-VITRO T-CELL FUNCTION, DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING, AND CD4(+) T-CELL SUBSET PHENOTYPING INDEPENDENTLY PREDICT SURVIVAL-TIME IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    DOLAN, MJ
    CLERICI, M
    BLATT, SP
    HENDRIX, CW
    MELCHER, GP
    BOSWELL, RN
    FREEMAN, TM
    WARD, W
    HENSLEY, R
    SHEARER, GM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) : 79 - 87
  • [10] INFLUENCE OF INTERLEUKIN-2 ADMINISTRATION ON THE EXPRESSION OF T-CELL RECEPTOR V-GENE SEGMENTS IN PATIENTS WITH RENAL-CELL CARCINOMA
    FARACE, F
    ANGEVIN, E
    ESCUDIER, B
    CAIGNARD, A
    DIETRICH, PY
    GENEVEE, C
    HERCEND, T
    TRIEBEL, F
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (05) : 741 - 747